NHPBP Company Profile and Key Details

National Healthcare Properties, Inc. earnings surprise history is a mixed track record. The quarter that ended August 05, 2026, missed forecasts by 13.04%.

Average 10-day trading volume of 17.91 thousand shares is slightly above the 3-month average of 15.76 thousand, indicating heightened recent market interest.

National Healthcare Properties, Inc. last paid a dividend of 1.78 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $0.00.

National Healthcare Properties, Inc. (NASDAQ:NHPBP) closed at $25.32 USD, gaining $0.02 (0.08%) from the previous close of $25.30. The stock is currently trading near its 52-week high $17.00 and $25.45. With a market capitalization of about $716.92 million, National Healthcare Properties, Inc. is classified as a small-cap and shows lower-than-market volatility (beta ~0.41). Key stats such as the average daily volume over the past year has been around 15.91 thousand shares, volume is running light vs its 52-week average. Headquartered in Newport, NY, National Healthcare Properties, Inc. operates in the Real Estate sector and the REIT - Healthcare Facilities industry. Led by CEO Michael R. Anderson, the company employs approximately 31 people and listed since October 04, 2021. Healthcare Trust, Inc. is a publicly listed real estate investment trust (REIT) that strategically builds its portfolio by acquiring a diverse range of healthcare properties across the United States.

Our AI price prediction model suggests that National Healthcare Properties, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term.

Valuation shows National Healthcare Properties, Inc. trading at a premium to the broader market with a P/E of -110.09.

National Healthcare Properties, Inc. trades at a P/E ratio of -110.09, slightly below the S&P 500 average, with a price-to-sales ratio of 2.08 and a price-to-book ratio of 1.48 suggesting the stock is closer to book value. The P/FCF stands at 30.15, also above market averages.